Inventor · disambiguated record
Sven Weiler
Also filed as: WEILER SVEN
12 granted patents·8 pending applications·28 citations·filing 2002–2021
86Inventor score
Top patents by PatentIndex Score
20 records- 0194US10947218B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2020·Granted Mar 16, 2021·6 cites·13 claims
- 0291US10710980B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·8 cites·6 claims
- 0381US8367662B2Organic compoundsNOVARTIS AG·Filed 2008·Granted Feb 5, 2013·7 cites·8 claims
- 0470US12466808B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 0564US7696216B2Aryl-quinazoline/aryl-2-amino-phenyl methanone derivativesNOVARTIS AG·Filed 2003·Granted Apr 13, 2010·2 cites·15 claims
- 0663US8476286B2Quinazoline derivatives which promote the release of parathyroid hormoneBEERLI RENE·Filed 2002·Granted Jul 2, 2013·5 cites·3 claims
- 0761US7977323B2C2-C5-alkyl-imidazole-bisphosphonatesNOVARTIS AG·Filed 2008·Granted Jul 12, 2011·0 cites·5 claims
- 0857US8569317B2Aryl-quinazoline/aryl-2amino-phenyl methanone derivativesALTMANN EVA·Filed 2009·Granted Oct 29, 2013·0 cites·3 claims
- 0953US2011112076A1Selective hydroxamic acid based mmp-12 and mmp-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2009·Application pending·0 cites
- 1051US2011257131A1Phenylalkyl-imidazole-bisphosphonate compoundsNOVARTIS AG·Filed 2009·Application pending·0 cites
- 1145US8841291B2Selective hydroxamic acid based MMP-12 and MMP-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2013·Granted Sep 23, 2014·0 cites·2 claims
- 1245US2010087491A1Polycyclic compoundsALBERT RAINER·Filed 2007·Application pending·0 cites
- 1345US2009318546A1Chromen-2-One DerivativesNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1444US2011224173A1C2-C5-Alkyl-Imidazole-BisphosphonatesNOVARTIS AG·Filed 2011·Application pending·0 cites
- 1542US2008306124A1Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor LigandsALBERT RAINER·Filed 2006·Application pending·0 cites
- 1642US2022402900A11,2,4-oxadiazol-5-one derivatives for the treatment of cancerBASILEA PHARM INT AG·Filed 2020·Application pending·0 cites
- 1742US2008200438A1Treatment of Autoimmune DiseasesALBERT RAINER·Filed 2006·Application pending·0 cites
- 1841US8143253B2Organic compoundsLIZOS DIMITRIOS·Filed 2008·Granted Mar 27, 2012·0 cites·7 claims
- 1941US8030497B2Benzimidazole derivativesNOVARTIS AG·Filed 2005·Granted Oct 4, 2011·0 cites·4 claims
- 2037US11160797B2Pyridinone derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Nov 2, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Sven Weiler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →